EU Acquires 110,000 Vaccine Doses To Fight Monkeypox

EU Acquires 110,000 Vaccine Doses To Fight Monkeypox
Monkeypox vaccine
WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print

The European Union on Tuesday revealed that it has purchased almost 110,000 vaccine doses to help tackle the monkeypox outbreak and would share them out among the bloc’s members.

The jabs, made by Danish firm Bavarian Nordic, are currently authorised for use in the EU against smallpox, but officials say they will also work against the monkeypox virus.

‘With the agreement signed today, we ensure that member states will have access to much-needed vaccines to protect people exposed to monkeypox,’ EU health commissioner Stella Kyriakides disclosed.

The World Health Organization says that, since the start of May, 1,285 monkeypox cases have been confirmed in 28 countries outside African nations where it is endemic.

Read Also: Nigeria, 5 Others To Begin Production Of Covid Vaccines –WHO

The EU says that around 900 cases have been reported in 19 countries across the bloc.

Monkeypox is closely related to smallpox, which killed millions around the world every year before it was eradicated in 1980, but has far less severe symptoms.

The EU said it would start deliveries of the vaccines to member states by the end of June and the deal also covered non-EU neighbours Norway and Iceland.

Meanwhile, the US Centers for Disease Control and Prevention (CDC) has stated that it was aware of more than 700 global cases of monkeypox, including 21 in the United States, with investigations now suggesting it is spreading inside the country.

According to a new CDC report, and 14 were thought to be travel-associated, about sixteen of the first 17 cases were among people who identify as men who have sex with men.

Africa Daily News, New York gathered that all patients are in recovery or have recovered, and no cases have been fatal.

Africa Daily News, New York

WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print